Form 8-K - Current report:
SEC Accession No. 0001493152-25-001323
Filing Date
2025-01-08
Accepted
2025-01-08 09:21:59
Documents
14
Period of Report
2025-01-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39545
2 ex99-1.htm EX-99.1 15396
  Complete submission text file 0001493152-25-001323.txt   236793

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE nrxs-20250108.xsd EX-101.SCH 3015
4 XBRL LABEL FILE nrxs-20250108_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE nrxs-20250108_pre.xml EX-101.PRE 24165
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3830
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41775 | Film No.: 25516804
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 03 Life Sciences)